Risk assessment of using off‐label morphine sulfate in a population‐based retrospective cohort of opioid‐dependent patients

MLA

Nicolas Authier, et al. “Risk Assessment of Using Off‐label Morphine Sulfate in a Population‐based Retrospective Cohort of Opioid‐dependent Patients.” British Journal of Clinical Pharmacology, vol. 86, Aug. 2019, pp. 2338–48. EBSCOhost, https://doi.org/10.1111/bcp.14082.

APA

Nicolas Authier, Denis Ardid, Jessica Delorme, Hélène Peyrière, Georges Brousse, Célian Bertin, Chouki Chenaf, Marie Riquelme, & Alain Eschalier. (2019). Risk assessment of using off‐label morphine sulfate in a population‐based retrospective cohort of opioid‐dependent patients. British Journal of Clinical Pharmacology, 86, 2338–2348. https://doi.org/10.1111/bcp.14082

Chicago

Nicolas Authier, Denis Ardid, Jessica Delorme, Hélène Peyrière, Georges Brousse, Célian Bertin, Chouki Chenaf, Marie Riquelme, and Alain Eschalier. 2019. “Risk Assessment of Using Off‐label Morphine Sulfate in a Population‐based Retrospective Cohort of Opioid‐dependent Patients.” British Journal of Clinical Pharmacology 86 (August): 2338–48. doi:10.1111/bcp.14082.